Search research articles
Contact Us
Filters
Showing results (41-50 of 164) with videos related to
Page
of 17
Sort By:
The British Journal of Dermatology
|
April 1, 1987
Adult linear IgA bullous dermatosis with bronchial involvement
F Verhelst, M Demedts, J Verschakelen, et al.
Anatomy and Embryology
|
May 30, 1998
Neurulation in the rabbit embryo
M C Peeters, C Viebahn, J W Hekking, et al.
Biochemical and Biophysical Research Communications
|
May 15, 1981
Subcellular distribution of coenzyme A: evidence for a separate coenzyme A pool in peroxisomes
A Van Broekhoven, M C Peeters, L J Debeer, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
Janneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Frontiers in Immunology
|
February 23, 2019
Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis
Lotte Nijhuis, Janneke G C Peeters, Sebastiaan J Vastert, et al.
Medical Microbiology and Immunology
|
January 1, 1992
Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates
C Peeters, A M Tenbergen-Meekes, J Poolmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2000
Morphological castes in a vertebrate
M J O'Riain, J U Jarvis, R Alexander, et al.
The EMBO Journal
|
June 3, 2000
Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo
M F de Bruijn, N A Speck, M C Peeters, et al.
Cell Reports
|
September 12, 2024
Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation
Janneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Regional Anesthesia
|
July 1, 1994
Survey of opioid use in chronic nonmalignant pain patients
R N Jamison, K O Anderson, C Peeters-Asdourian, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 164) with videos related to
Sort By:
Page
of 17
The British Journal of Dermatology
|
April 1, 1987
Adult linear IgA bullous dermatosis with bronchial involvement
F Verhelst, M Demedts, J Verschakelen, et al.
Anatomy and Embryology
|
May 30, 1998
Neurulation in the rabbit embryo
M C Peeters, C Viebahn, J W Hekking, et al.
Biochemical and Biophysical Research Communications
|
May 15, 1981
Subcellular distribution of coenzyme A: evidence for a separate coenzyme A pool in peroxisomes
A Van Broekhoven, M C Peeters, L J Debeer, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
Janneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Frontiers in Immunology
|
February 23, 2019
Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis
Lotte Nijhuis, Janneke G C Peeters, Sebastiaan J Vastert, et al.
Medical Microbiology and Immunology
|
January 1, 1992
Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates
C Peeters, A M Tenbergen-Meekes, J Poolmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2000
Morphological castes in a vertebrate
M J O'Riain, J U Jarvis, R Alexander, et al.
The EMBO Journal
|
June 3, 2000
Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo
M F de Bruijn, N A Speck, M C Peeters, et al.
Cell Reports
|
September 12, 2024
Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation
Janneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Regional Anesthesia
|
July 1, 1994
Survey of opioid use in chronic nonmalignant pain patients
R N Jamison, K O Anderson, C Peeters-Asdourian, et al.
Page
of 17